RU2019101194A3 - - Google Patents

Download PDF

Info

Publication number
RU2019101194A3
RU2019101194A3 RU2019101194A RU2019101194A RU2019101194A3 RU 2019101194 A3 RU2019101194 A3 RU 2019101194A3 RU 2019101194 A RU2019101194 A RU 2019101194A RU 2019101194 A RU2019101194 A RU 2019101194A RU 2019101194 A3 RU2019101194 A3 RU 2019101194A3
Authority
RU
Russia
Application number
RU2019101194A
Other languages
Russian (ru)
Other versions
RU2795195C2 (ru
RU2019101194A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019101194A publication Critical patent/RU2019101194A/ru
Publication of RU2019101194A3 publication Critical patent/RU2019101194A3/ru
Application granted granted Critical
Publication of RU2795195C2 publication Critical patent/RU2795195C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
RU2019101194A 2016-06-21 2017-06-21 Ингибиторы альдозоредуктазы и способы их применения RU2795195C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662352784P 2016-06-21 2016-06-21
US62/352,784 2016-06-21
PCT/US2017/038505 WO2017223179A1 (en) 2016-06-21 2017-06-21 Aldose reductase inhibitors and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2023110864A Division RU2023110864A (ru) 2016-06-21 2017-06-21 Ингибиторы альдозоредуктазы и способы их применения

Publications (3)

Publication Number Publication Date
RU2019101194A RU2019101194A (ru) 2020-07-23
RU2019101194A3 true RU2019101194A3 (enExample) 2020-08-31
RU2795195C2 RU2795195C2 (ru) 2023-05-02

Family

ID=

Also Published As

Publication number Publication date
DK3757107T3 (da) 2023-11-27
US20200283451A1 (en) 2020-09-10
JP7368419B2 (ja) 2023-10-24
AU2017281082A1 (en) 2018-12-06
JP2019518779A (ja) 2019-07-04
US20180237451A1 (en) 2018-08-23
SI3757107T1 (sl) 2024-02-29
CN109310674B (zh) 2022-07-08
JP2025124733A (ja) 2025-08-26
IL263631A (en) 2019-01-31
US12077547B2 (en) 2024-09-03
SG11201810642XA (en) 2019-01-30
JP6895464B2 (ja) 2021-06-30
DK3352754T3 (da) 2020-12-07
JP7688681B2 (ja) 2025-06-04
AU2023204218B2 (en) 2025-09-11
JP2021130719A (ja) 2021-09-09
FI3757107T3 (fi) 2023-12-12
IL304979A (en) 2023-10-01
EP4316603A2 (en) 2024-02-07
RS61239B1 (sr) 2021-01-29
HRP20231563T1 (hr) 2024-03-15
BR112018076244A2 (pt) 2019-03-26
LT3352754T (lt) 2021-02-25
MX2021014938A (es) 2022-01-24
NZ748506A (en) 2025-07-25
PT3757107T (pt) 2023-12-14
HK1259379A1 (en) 2019-11-29
US20190300543A1 (en) 2019-10-03
ZA201808506B (en) 2020-05-27
AU2025275331A1 (en) 2026-01-22
AU2021203801B2 (en) 2023-04-06
US10870658B2 (en) 2020-12-22
EP3757107B1 (en) 2023-10-25
EP3757107A1 (en) 2020-12-30
SG10202012188VA (en) 2021-01-28
IL283809B1 (en) 2023-09-01
CN115160339A (zh) 2022-10-11
SI3352754T1 (sl) 2021-03-31
US11498925B2 (en) 2022-11-15
ES2836500T3 (es) 2021-06-25
AU2021203801A1 (en) 2021-07-15
EP3352754B1 (en) 2020-09-02
HUE064911T2 (hu) 2024-04-28
CN109310674A (zh) 2019-02-05
EP3352754A1 (en) 2018-08-01
RU2019101194A (ru) 2020-07-23
IL263631B (en) 2021-07-29
EP4316603A3 (en) 2024-04-17
US10150779B2 (en) 2018-12-11
MX2018016122A (es) 2019-08-01
HUE052101T2 (hu) 2021-04-28
EP3352754A4 (en) 2019-04-17
IL283809A (en) 2021-07-29
AU2017281082B2 (en) 2021-03-18
AU2023204218A1 (en) 2023-07-27
MX391561B (es) 2025-03-21
US10647726B2 (en) 2020-05-12
US20210284652A1 (en) 2021-09-16
US20250163073A1 (en) 2025-05-22
HRP20201905T1 (hr) 2021-01-22
JP2023171614A (ja) 2023-12-01
CA3025081A1 (en) 2017-12-28
IL283809B2 (en) 2024-01-01
CN115160339B (zh) 2024-05-14
PT3352754T (pt) 2020-12-07
LT3757107T (lt) 2023-12-11
PL3757107T3 (pl) 2024-03-18
ES2966094T3 (es) 2024-04-18
WO2017223179A1 (en) 2017-12-28
US20230312599A1 (en) 2023-10-05

Similar Documents

Publication Publication Date Title
BR112019002665A2 (enExample)
BR112018004986A2 (enExample)
BR112019009366A2 (enExample)
BR112019001429A2 (enExample)
BR112018004348A2 (enExample)
BR212018070320U2 (enExample)
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112018069468B1 (pt) Uso de um agente indutor da imunidade
BR112019006736A2 (enExample)
BR112019003108A2 (enExample)
BR122020010433A2 (enExample)
CN303648031S (zh) 智能手机(nx523j)
CN303614020S (zh) 可调角度型感应灯(my-84055)
CN303634801S (zh) 遥控器
CN303613700S (zh) 蜡烛灯底座(圆形)
CN303641057S (zh) 装订机(惠朗)
CN303634787S (zh) 用于手机的图形用户界面
CN303611042S (zh) 茶叶盒
CN303585503S (zh) 顶端隔振器
CN303537476S (zh) 飞碟吊椅
CN303536045S (zh) 嫁衣(15)